Indivior Pharmaceuticals (INDV) Operating Margin (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Operating Margin of 43.22% for Q1 2026, up 1841.0% year-over-year from 2.23% in Q1 2025, and up 91.01% quarter-over-quarter from 22.63% in Q4 2025.
Indivior Pharmaceuticals (INDV) Operating Margin (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Operating Margin history runs 3 years deep, the most recent figure standing at 43.22% for Q1 2026.
- In Q1 2026, Operating Margin rose 1841.0% year-over-year to 43.22%; the TTM figure through Mar 2026 stood at 25.79% (up 2332.0% YoY), while the FY2025 annual figure was 21.15%, up 1795.0% from the prior year.
- Operating Margin for Q1 2026 stood at 43.22%, up from 22.63% in the prior quarter.
- The five-year high for Operating Margin was 43.22% in Q1 2026, with the low at 39.46% in Q2 2024.
- The 3-year median for Operating Margin is 22.63% (2025), against an average of 15.77%.
- Peak annual rise in Operating Margin reached 6331 bps in 2025, while the deepest fall reached 160 bps in 2025.
- Indivior Pharmaceuticals' Operating Margin stood at 15.38% in 2024, then surged by 47 bps to 22.63% in 2025, then jumped by 91 bps to 43.22% in 2026.
- Business Quant data shows INDV's Operating Margin at 43.22% in Q1 2026, 22.63% in Q4 2025, and 13.69% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.54 Bn | 4.32 Bn | 294.00 Mn | 46.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.65% |
| Mar 31, 2026 | 43.22% |
| Dec 31, 2025 | 22.63% |
| Sep 30, 2025 | 13.69% |
| Jun 30, 2025 | 23.84% |
| Mar 31, 2025 | 24.81% |
| Dec 31, 2024 | 15.38% |
| Sep 30, 2024 | 11.40% |
| Jun 30, 2024 | -39.46% |
| Mar 31, 2024 | 26.41% |